Search Results - "Shmidt, A E"

Prognostic factors in patients with non-ST-segment elevation acute coronary syndrome concurrent with type 2 diabetes mellitus (according to the results of the registry) by Golikov, A P, Berns, S A, Stryuk, R I, Shmidt, E A, Golikova, A A, Barbarash, O L

“…To investigate factors that influence annual prognosis in patients with non-ST-segment elevation acute coronary syndrome ((NSTEACS) concurrent with type 2…”
Get full text

A poor outcome prediction scale in ST-segment elevation myocardial infarction patients undergoing emergency percutaneous coronary intervention by Shmidt, E A, Berns, S A, Osokina, A V, Klimenkova, A V, Chuvichkina, O V

“…To make a prediction scale using a set of clinical and laboratory prognostic variables for patients with ST-segment elevation myocardial infarction (STEMI) on…”
Get full text

Coagulation status in patients with pulmonary embolism receiving long-term anticoagulant therapy by Shmidt, E. A., Berns, S. A., Penskaya, T. Yu, Zhidkova, I. I., Gruzdeva, O. V., Barbarash, O. L.

“…Aim. To study the blood coagulation status by various laboratory methods in patients after pulmonary embolism (PE) receiving long-term anticoagulant therapy…”
Get full text

Incidence and prognostic value of acute kidney injury in pulmonary embolism: data from the SIRENA registry by Menzorov, M. V., Filimonova, V. V., Erlikh, A. D., Barbarash, O. L., Berns, S. A., Shmidt, E. A., Duplyakov, D. V.

“…Aim. To evaluate the incidence and severity of acute kidney injury (AKI), as well as its ability to reclassify the risk of premature mortality and association…”
Get full text

SIRENA score for in-hospital mortality risk assessment in patients with acute pulmonary embolism by Erlikh, A. D., Barbarash, O. L., Berns, S. A., Shmidt, E. A., Duplyakov, D. V.

“…Aim. To create a new prognostic scale for in-hospital mortality risk assessment in patients with pulmonary embolism (PE).Material and methods. The study was…”
Get full text

Renal dysfunction in patients with pulmonary embolism: data from the SIRENA register by Menzorov, M. V., Filimonova, V. V., Erlikh, A. D., Barbarash, O. L., Berns, S. A., Shmidt, E. A., Duplyakov, D. V.

“…Aim. To assess the prevalence, severity and prognostic value of renal dysfunction (RD) in patients with pulmonary embolism (PE) of the Russian population, as…”
Get full text

Features of in-hospital clinical course of pulmonary embolism in patients of different age groups by Shmidt, E. A., Berns, S. A., Neeshpapa, A. G., Talyzin, P. A., Zhidkova, I. I., Mamchur, I. N., Potapenko, A. A., Chukalenko, D. A., Barbarash, O. L.

“…Aim. To study the clinical course and management of patients with pulmonary embolism (PE) of various age groups hospitalized in a cardiology hospital. Material…”
Get full text

Russian register of acute pulmonary embolism SIRENA: characteristics of patients and in-hospital treatment by Erlikh, A. D., Atakanova, A. N., Neeshpapa, A. G., Cherepanova, N. A., Mullova, I. S., Barbarash, O. L., Berns, S. A., Shmidt, E. A., Duplyakov, D. V.

“…Aim. To assess the features of diagnosis, treatment and outcomes of pulmonary embolism (PE) in patients of Russian hospitals. Material and methods. The…”
Get full text

Assessment of Outcomes and Treatment Tactics in Patients With Non-ST-Elevation Acute Coronary Syndrome: Data of Five-Year Follow-up by Berns, S A, Shmidt, E A, Nagirnyak, O A, Klimenkova, A V, Litvinova, M N, Sergeeva, T Y, Barbarash, O L

“…to study the role of clinical factors and treatment tactics in the development of adverse outcomes in patients with non-STelevation acute coronary syndrome…”
Get more information

ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION by Shmidt, E. A., Berns, S. A., Zhidkova, I. I., Makeeva, O. A., Goncharova, I. A., Nagirnyak, O. A., Klimenkova, A. V., Litvinova, M. N., Barbarash, O. L.

“…Lymphotoxin-α (LTA) is a major pro-inflammatory cytokine produced at the early stages of vascular inflammation, taking part in the formation of arterial…”
Get full text

DYNAMICS OF CYTOKINE LEVELS IN THE HOSPITALIZED PATIENTS WITH DIFFERENT CLINICAL TYPES OF ACUTE CORONARY SYNDROME by Berns, S. A., Kiprina, E. S., Shmidt, E. A., Veremeev, A. V., Barbarash, O. L.

“…The study included 120 patients with acute coronary syndrome (ACS), which were divided: in two groups, respectively, with ACS-ST segment elevation (group 1, n…”
Get full text

Introduction of additional thiol groups into glucoamylase in Aspergillus awamori and their effect on the thermal stability and catalytic activity of the enzyme by Surzhik, M A, Shmidt, A E, Glazunov, E A, Firsov, D L, Petukhov, M G

“…Five mutant forms of glucoamylase (GA) from the filamentous fungus Aspergillus awamori with artificial disulfide bonds (4D-G137A\A14C, 6D-A14C\Y419C\G137A,…”
Get more information

Influence of Endothelial Dysfunction on Prognosis of Patients With Non ST-Segment Elevation Acute Coronary Syndrome by Berns, S A, Shmidt, E A, Yuchno, E S, Nagirnyak, O A, Homyakova, T A, Barbarash, O L

“…We studied relationship between markers of endothelial dysfunction and multifocal atherosclerosis and adverse coronary events in 82 patients with non-ST…”
Get more information

THE RELATIONSHIP BETWEEN POLYMORPHISMS OF G-1082A AND C-592A LOCI OF THE IL10 GENE AND MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT SEGMENT ST ELEVATION by Berns, S A, Shmidt, E A, Makeeva, O A, Golikova, A A, Ivanova, T B, Nagirnyak, O A, Barbarash, O L

“…To study the relationship between polymorphous G-1082A (rs3024491) and C-592A (rs1800872) variants of the IL10 gene and multifocal atherosclerosis (MFA) in…”
Get more information

The role of multifocal atherosclerosis in realization of new cardiovascular complications during one year after non ST-elevation acute coronary syndrome by Berns, S A, Zykova, D S, Zykov, M V, Shmidt, E A, Iukhno, E S, Nagirniak, O A, Barbarash, O L

“…to assess prognostic value of multifocal atherosclerosis (MFA) relative to risk of new cardiovascular catastrophes in patients with non ST elevation acute…”
Get more information

effect of point amino acid substitutions in an internal α-helix on thermostability of Aspergillus awamori X100 glucoamylase by Surzhik, M. A, Churkina, S. V, Shmidt, A. E, Shvetsov, A. V, Kozhina, T. N, Firsov, D. L, Firsov, L. M, Petukhov, M. G

“…Conformational flexibility of α-helices in glucoamylase of the fungus Aspergillus awamori was studied by molecular dynamics methods. Several amino acid…”
Get full text

Predictors of stent thrombosis in patients with ST-elevation acute coronary syndrome subjected to primary coronary artery intervention by Berns, S A, Shmidt, E A, Kiprina, E S, Barbarash, O L, Veremeev, A V, Gruzdeva, O V, Moiseenkov, G V

“…Basing on complex evaluation of clinical, angiographic, and laboratory data we revealed predictors of stent thrombosis in patients with ST-elevation acute…”
Get more information

The effect of point amino acid substitutions in an internal alpha-helix on thermostability of Aspergillus awamori X100 glucoamylase by Surzhik, M A, Churkina, S V, Shmidt, A E, Shvetsov, A V, Kozhina, T N, Firsov, D L, Firsov, L M, Petukhov, M G

“…Conformational flexibility of alpha-helices in glucoamylase of the fungus Aspergillus awamori was studied by molecular dynamics methods. Several amino acid…”
Get more information

Predictors of coronary adverse events in patients with acute coronary syndrome with ST segment elevation treated with percutaneous coronary interventions with stenting by Berns, S A, Shmidt, E A, Kiprina, E S, Klimenkova, A V, Barbarash, O L, Sin'kov, M V, Moiseenkov, G V, Barbarash, L S

“…The aim of this 12 months observational study was to investigate risk factors of major adverse coronary events, such as death or Q wave myocardial infarction…”
Get more information

Long-term oxygen treatment in chronic respiratory failure by Nuralieva, G. S., Shmidt, A. E., Avdeev, I. S., Nekludova, G. V.

“…Chronic respiratory failure (CRF) is the leading cause of mortality in patients with pulmonary diseases. One of the key treatments for CRF is long-term oxygen…”
Get full text